Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
Morris MC, Richman S, Lyman CA, Qu J, Mammen MJ, Sethi S, Broderick, G. Hacking the Immune Response to Infection in Chronic Obstructive Pulmonary Disease.. 20th IEEE International Conference on Bioinformatics and Bioengineering (IEEE BIBE 2020). 2020
Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.
The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD). Manoj Mammen (Co-Investigator). Department of Defense, U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs. $1,057,527. 10/1/2020-8/1/2022.
Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.
Impact of Advanced Therapy on Mental Health in Cystic Fibrosis (CF). Carla Frederick (Co-Investigator), Danielle Goetz (Co-Investigator). University at Buffalo Office of Research and Economic Development. $25,000. 9/1/2020-8/1/2021.
Evaluating Determinants of PK, Tissue Distribution, and Efficacy of siRNA-antibody Conjugates. Sukyung Woo (Principal Investigator). Center for Protein Therapeutics. $100,000. 9/1/2020-8/1/2021.
Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging. Collin Clark (Co-Investigator), Christopher Daly (Co-Investigator), David Jacobs (Co-Investigator), Scott Monte (Co-Investigator), Ranjit Singh (Co-Principal Investigator), Robert Wahler (Co-Principal Investigator). US Deprescribing Research Network. $60,000. 8/1/2020-7/1/2021.
Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Thomas Russo (Principal Investigator). NIH. $431,682. 8/1/2020-7/1/2022.
Goldwave Biotechnology. Praveen Arany (Principal Investigator). $30,000. 8/1/2020-11/1/2020.
High Speed Angiography at 1000 frames per second. Stephen Rudin (Principal Investigator). NIH. $2,605,210. 8/1/2020-4/1/2024.
An inflammation-induced fibrosis-on-chip system for the testing of anti-fibrosis drugs. Ruogang Zhao (Principal Investigator). National Heart, Lung, and Blood Institute. $920,000. 7/1/2020-7/1/2022.
A Novel Approach to Bradycardia during Preterm Neonatal Resuscitation Using an Ovine Model of Asphyxia. Praveen Chandrasekharan (Principal Investigator). ZOLL Foundation. $50,000. 7/1/2020-7/1/2022.
Comparison of triple therapy with apixaban vs. rivaroxabn. Maya Chilbert (Principal Investigator), David Jacobs (Co-Investigator), Ashley Woodruff (Co-Investigator). American College of Clinical Pharmacy Cardiology PRN. 7/1/2020-6/1/2021.
